{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"neurometabolic-disorder-due-to-serine-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Serine-deficiency syndrome is a very rare infantile-onset potentially treatable neurometabolic disorder characterized clinically by microcephaly, neurodevelopmental disorders and seizures. Three serine-deficiency syndromes have been described: 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, 3-phosphoserine phosphatase (3-PSP) deficiency, and phosphoserine aminotransferase deficiency.","mondoId":"MONDO:0018162","node":{"canonicalSlug":"neurometabolic-disorder-due-to-serine-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"neurometabolic disorder due to serine deficiency","paragraphs":["Serine-deficiency syndrome is a very rare infantile-onset potentially treatable neurometabolic disorder characterized clinically by microcephaly, neurodevelopmental disorders and seizures. Three serine-deficiency syndromes have been described: 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, 3-phosphoserine phosphatase (3-PSP) deficiency, and phosphoserine aminotransferase deficiency."],"scope":"exact","source":"MONDO","upstream":"Orphanet:35705","url":"https://monarchinitiative.org/MONDO:0018162"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"inborn serine deficiency","mondoId":"MONDO:0000421","slug":"inborn-serine-deficiency"},{"kind":"parent","label":"inborn disorder of serine family metabolism","mondoId":"MONDO:0019239","slug":"inborn-disorder-of-serine-family-metabolism"},{"kind":"child","label":"PSAT deficiency","mondoId":"MONDO:0012596","slug":"psat-deficiency"},{"kind":"child","label":"PSPH deficiency","mondoId":"MONDO:0013531","slug":"psph-deficiency"},{"kind":"child","label":"spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome","mondoId":"MONDO:0014725","slug":"spastic-tetraplegia-thin-corpus-callosum-progressive-postnatal-microcephaly"},{"kind":"child","label":"3-phosphoglycerate dehydrogenase deficiency","mondoId":"MONDO:0018491","slug":null},{"kind":"child","label":"serine biosynthesis pathway deficiency, infantile/juvenile form","mondoId":"MONDO:0035004","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18815"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018162\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:35705</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Serine-deficiency syndrome is a very rare infantile-onset potentially treatable neurometabolic disorder characterized clinically by microcephaly, neurodevelopmental disorders and seizures. Three serine-deficiency syndromes have been described: 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, 3-phosphoserine phosphatase (3-PSP) deficiency, and phosphoserine aminotransferase deficiency.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018162\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"neurometabolic-disorder-due-to-serine-deficiency","sourceDocuments":[{"name":"MONDO: neurometabolic disorder due to serine deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018162"}],"sourceNote":"","synonyms":["neurometabolic disorder due to serine deficiency","serine deficiency"],"takeawayHtml":"","title":"neurometabolic disorder due to serine deficiency"},"schemaVersion":1}
